KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $5,966,000 | -28.7% | 57,550 | -46.0% | 0.11% | -30.9% |
Q1 2017 | $8,364,000 | -21.1% | 106,550 | -55.0% | 0.16% | -33.3% |
Q4 2016 | $10,606,000 | +58.8% | 236,550 | +97.9% | 0.24% | +50.9% |
Q3 2016 | $6,678,000 | -25.6% | 119,550 | -33.4% | 0.16% | -30.9% |
Q2 2016 | $8,978,000 | +42.0% | 179,550 | +29.6% | 0.23% | +47.5% |
Q1 2016 | $6,324,000 | -18.5% | 138,500 | +9.9% | 0.16% | -24.0% |
Q4 2015 | $7,764,000 | +58.1% | 126,000 | +42.9% | 0.21% | +71.9% |
Q3 2015 | $4,911,000 | +11.9% | 88,200 | +22.5% | 0.12% | +33.0% |
Q2 2015 | $4,390,000 | -4.9% | 72,000 | -10.0% | 0.09% | -2.2% |
Q1 2015 | $4,615,000 | +11.2% | 80,000 | +11.1% | 0.09% | +6.9% |
Q4 2014 | $4,152,000 | – | 72,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |